177lu-psma-617
novartis
[' vision', 'crpc', 'great job']
andrew armstrong did a great job standing in for phillip kuo presenting in today's genitourinary cancer session at #asco22 on the vision substudy. for psma+ mcrpc treated with 177lu-psma-617; patients in the highest suv quartile had rpfs of 14.1m and os of 21.4m. 
Independent and international experts in GenitoUrinary (GU) oncology. Part of https://t.co/QAbKORwRcf